BOTHELL, Wash., Feb. 13 Cardiac ScienceCorporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis,resuscitation, rehabilitation, and informatics products, announced today thatit will present at the Roth Capital Partners 20th Annual OC Growth StockConference on Wednesday, February 20, 2008 at the Ritz Carlton Laguna Nigel.Mike Matysik, the company's senior vice president and chief financial officer,will present the Company's business strategy and third quarter financialresults at 8:30 a.m. Pacific Time.
Attendance at the conference is by invitation only. Cardiac Science willoffer a live audio webcast of its presentation, which may be accessed at theCompany's website at http://www.cardiacscience.com. An archived replay of thepresentation will also be available following the live presentation and can beaccessed at http://www.cardiacscience.com.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanceddiagnostic and therapeutic cardiology devices and systems, including AEDs,electrocardiographs, stress test systems, Holter monitoring systems, hospitaldefibrillators, cardiac rehabilitation telemetry systems, and cardiology datamanagement systems (informatics) that connect with hospital information (HIS),electronic medical record (EMR), and other information systems. The Companysells a variety of related products and consumables, and provides a portfolioof training, maintenance, and support services. Cardiac Science, thesuccessor to the cardiac businesses that established the trusted Burdick(R),HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered inBothell, Washington. With customers in more than 100 countries worldwide, thecompany has operations in North America, Europe, and Asia. For information,call 425-402-2000 or visit http://www.cardiacscience.com.Company Contact: Mike Matysik Cardiac Science Corporation Sr. Vice President and CFO (425) 402-2009 Investor Contact: Doug Sherk/Jenifer Kirtland EVC Group, Inc. (415) 896-6820 Media Contact: Christopher Gale EVC Group, Inc. (201) 646-5431 (203) 570-4681 email@example.com
SOURCE Cardiac Science Corporation